ABVC BioPharma, Inc. Deferred Compensation Arrangement with Individual, Exercise Price
ABVC BioPharma, Inc. (ABVC) reported Deferred Compensation Arrangement with Individual, Exercise Price of $1.05 per share for the 1-month period ending 2023-02-23, per its 10-Q filed 2023-11-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DeferredCompensationArrangementWithIndividualExercisePrice · last filed 2023-11-15
- 2023-02-23: Deferred Compensation Arrangement with Individual, Exercise Price 1 month $1.05.
| Period end | Deferred Compensation Arrangement with Individual, Exercise Price 1 month |
|---|---|
| 2023-02-23 | $1.05 10-Q · filed 2023-11-15 |